Disclaimer: This tool is for visualization and illustrative purposes only and is not a substitute for a consultation with a qualified healthcare professional. When you decide on and consult with a qualified healthcare provider, he/she will determine the severity of your wrinkles and folds and will determine if JUVÉDERM™ injectable gel is appropriate. He/she may recommend a different treatment based on your individual needs to help you achieve your desired result. Allergan and Juvederm.com do not endorse or warrant any specific technique, method of treatment, or outcome. Allergan and Juvederm.com are not engaged in providing medical advice or services. It is up to your individual healthcare professional to use his/her best medical judgment when making recommendations and determining appropriate patient care or treatment techniques.


Important JUVÉDERM™ Treatment Considerations

Juvéderm™ Ultra and Juvéderm™ Ultra Plus are indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate lasting 7 days or less and included temporary injection site reactions like redness, pain, firmness, swelling and bumps. For more information, please click on the “About Safety” link, or call the Allergan Product Support line at 1-877-345-5372.


 

BOTOX® Cosmetic is approved for the temporary treatment of moderate to severe frown lines between the brows in people ages 18-65.


Important Safety Information about BOTOX® Cosmetic


Serious heart problems and serious allergic reactions have been reported rarely. If you think you're having an allergic reaction or other unusual symptoms, such as difficulty swallowing, speaking or breathing, call your doctor immediately. The most common side effects following injection include temporary eyelid droop and nausea. Localized pain, infection, inflammation, tenderness, swelling, redness and/or bleeding/bruising may be associated with the injection. Patients with certain neuromuscular disorders such as ALS, myasthenia gravis or Lambert-Eaton syndrome may be at increased risk of serious side effects.